| Author | Jalil, Cristina Moreira | |
| Author | Teixeira, Sylvia Lopes Maia | |
| Author | Coutinho, Carolina Fausto de Souza | |
| Author | Costa, Sandro Coutinho Nazer da | |
| Author | Carvalheira Netto, Eduardo | |
| Author | Hoagland, Brenda Regina de Siqueira | |
| Author | Cardoso, Sandra Wagner | |
| Author | Luz, Paula Mendes | |
| Author | Veloso, Valdiléa G. | |
| Author | Grinsztejn, Beatriz | |
| Author | Jalil, Emilia Moreira | |
| Author | Torres, Thiago Silva | |
| Access date | 2024-12-11T17:36:27Z | |
| Available date | 2024-12-11T17:36:27Z | |
| Document date | 2025 | |
| Citation | JALIL, Cristina Moreira et al. Impact of COVID-19 pandemic on HIV testing, recent infections, and annualized incidence among cisgender men who have sex with men and transgender women in Brazil. Journal of Acquired Immune Deficiency Syndrome, v. 98, n. 1, p. 12-19, 1 Jan. 2025. | |
| ISSN | 1525-4135 | |
| URI | https://www.arca.fiocruz.br/handle/icict/67536 | |
| Description | Produção científica do Laboratório de Aids e Imunologia Molecular. | pt_BR |
| Description | Supplemental Digital Content: this article contains supplemental content that can be downloaded by clicking a link in the full text: https://links.lww.com/QAI/C366 | en_US |
| Sponsorship | The authors would like to thank all study participants. Thiago Silva Torres was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq; #311871/2021-6 and #402916/2021-2) and Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ #E-26/201.270/2022 and #E-26/211.577/2021). Paula Mendes Luz was supported by CNPq (#316401/2021-8) and FAPERJ (#E-26/201.133/2021). Beatriz Gilda Jegerhorn Grinsztejn was supported by CNPq (#313265/2023-2) and FAPERJ (#E.26/200.946/2022). | |
| Language | eng | en_US |
| Publisher | Lippincott, Williams & Wilkins | |
| Previous version | https://www.arca.fiocruz.br/handle/icict/66071 | |
| Rights | open access | |
| Title | Impact of COVID-19 pandemic on HIV testing, recent infections, and annualized incidence among cisgender men who have sex with men and transgender women in Brazil | en_US |
| Type | Article | |
| DOI | 10.1097/QAI.0000000000003531 | |
| Abstract | Background: The COVID-19 pandemic had great impact on HIV care and prevention worldwide, including in Brazil. We compared HIV testing, recent infection, and annualized incidence according to the COVID-19 pandemic period among cisgender men who have sex with men (MSM) and transgender women (TGW). Setting: HIV and sexually transmitted infection testing, prevention, and treatment referral service in Rio de Janeiro, Brazil. Methods: We used Maxim HIV-1 Limiting Antigen Avidity EIA as part of a recent infection testing algorithm to identify recent HIV infection cases and estimate annualized HIV incidences in the pre- (March 2018–February 2020) and post-COVID-19 pandemic onset period (March 2020–January 2022). Multivariable logistic regression model assessed factors associated with recent HIV infection. Results: Among 3814 MSM and 776 TGW, 593 (12.9%) tested positive for HIV and 119 (2.6%) were identified as having recent infection. Percentage of recent HIV infection did not differ between the COVID-19 periods. Overall annualized HIV incidence rates were 6.0% (95% confidence interval [CI]: 4.2 to 7.7) and 6.6% (95% CI: 4.3 to 9.0) in the pre- and post-COVID-19 periods, respectively. During the post-COVID-19 period, higher incidence rates were observed among TGW (8.4% [95% CI: 2.9 to 13.9]), those aged 18–24 years (7.8% [95% CI: 4.0 to 11.7]), of Black race (7.9% [95% CI: 3.8 to 12.0]), and those with <12 years of schooling (7.8% [95% CI: 4.8 to 10.8]). Compared to the pre-COVID-19 period, incidence rates were significantly higher in the post-COVID-19 period for those aged >30 years and TGW, while being lower for those with more years of schooling. Conclusion: HIV incidence estimates remain high among MSM and TGW in Brazil, especially among the most vulnerable. The consequences of the COVID-19 pandemic on the HIV epidemic will likely persist and contribute to worsening HIV outcomes. | en_US |
| Affilliation | Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil. | |
| Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Aids e Imunologia Molecular. Rio de Janeiro, RJ, Brasil. | |
| Affilliation | Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil. | |
| Affilliation | Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil. | |
| Affilliation | Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil. | |
| Affilliation | Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil. | |
| Affilliation | Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil. | |
| Affilliation | Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil. | |
| Affilliation | Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil. | |
| Affilliation | Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil. | |
| Affilliation | Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil. | |
| Affilliation | Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil. | |
| Subject | Recent HIV infection | en_US |
| Subject | HIV incidence | en_US |
| Subject | COVID-19 | en_US |
| Subject | Men who have sex with men | en_US |
| Subject | Transgender women | en_US |
| Subject | Sexual and gender minorities | en_US |
| e-ISSN | 1077-9450 | |
| xmlui.metadata.dc.subject.ods | 03 Saúde e Bem-Estar | |
| xmlui.metadata.dc.subject.ods | 05 Igualdade de gênero | |
| xmlui.metadata.dc.subject.ods | 10 Redução das desigualdades | |
| xmlui.metadata.dc.subject.ods | 17 Parcerias e meios de implementação | |
